Open AccessA Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Author(s) -
Jin Yong Kim,
Oana Săndulescu,
Liliana Preoțescu,
Norma E. Rivera-Martínez,
Marta Dobryanska,
Victoria Bîrluțiu,
Egidia Miftode,
Natalia Gaibu,
Olga Adriana Căliman-Sturdza,
Simin Aysel Florescu,
Hye Jin Shi,
Adrian StreinuCercel,
Sang Joon Lee,
Sung Hyun Kim,
Ilsung Chang,
Yun Ju Bae,
Jee Hye Suh,
Da Rae Chung,
Sun Jung Kim,
Mi Rim Kim,
Seul Gi Lee,
Gahee Park,
Joong Sik Eom
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac406
Subject(s) - medicine , randomized controlled trial , clinical endpoint , placebo , adverse effect , confidence interval , clinical trial , gastroenterology , surgery , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom